Reirradiation as a Component of the Multidisciplinary Management of Locally Recurrent Breast Cancer
Authors:
- Matthew M. HarkenriderMHMatthew M. Harkenrider
- Mary R. WilsonMWMary R. Wilson
- Anthony E. DragunADAnthony E. Dragun
- 1 June 2011
- journal article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 11 (3) , 171-176
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized TrialJNCI: Journal of the National Cancer Institute, 2005
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trialAnnals of Oncology, 2001
- 10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: A Randomized TrialJournal of Clinical Oncology, 1999
- Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trialThe Lancet, 1999
- Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgeryBritish Journal of Surgery, 1999
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an UpdateJNCI: Journal of the National Cancer Institute, 1996
- Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trialThe Lancet, 1996